Iqonga le-DTP leCaryHealth lenza inkqubo yonyango lweNatroba (echinococcin) ibe lula ngokutshintsha iinkqubo ezahlukeneyo zokhathalelo olubonakalayo ngemodeli engenamthungo, egxile kwisigulane.
IWASHINGTON, nge-7 ka-Epreli, ngo-2026 — (BUSINESS WIRE) — ICaryHealth, inkampani ephambili yezempilo yedijithali, namhlanje ibhengeze intsebenziswano neCipher Pharmaceuticals US LLC (Cipher okanye Cipher Pharmaceuticals) ukuqalisa iqonga layo eliya ngqo kwisigulane (DTP), elenzelwe ukubonelela izigulane ngokufikelela lula kwiyeza elibhalwe ngugqirha iNatroba (spinosad), elisetyenziselwa ukunyanga iintwala zentloko kunye nokhwekhwe. Njengenxalenye yale ntsebenziswano, iCaryHealth iphuhlise iqonga elikwi-intanethi elenzelwe wena elivumela izigulane ukuba zifikelele kwaye zithathe iNatroba (spinosad) ngokukhawuleza, zisusa imiqobo eqhelekileyo izigulane ezijongene nayo xa zisebenzisa iinkonzo zempilo ezibonakalayo.
“Iintsapho ezijongene neentwala kunye nokhwekhwe zifuna isisombululo esikhawulezayo nesilula sokufumana amayeza angcono nasebenzayo,” utshilo uBrian Jacobs, uMongameli weMisebenzi yase-US yeCipher Pharmaceuticals. “Ngokubambisana kwethu neCaryHealth, sinikezela ngokuthathwa okanye ukuhanjiswa ekhaya ecaleni kwendlela, okwenza kube lula kwaye kukhawuleze ukuba izigulane zifikelele kwiNatroba™ okanye inguqulelo yayo yesiqhelo enelayisenisi, i-spinosad. Amayeza ekhemesti yendabuko ayisasebenzi, kodwa amayeza amiselweyo eNatroba™ (spinosad) anika isiqabu ngokukhawuleza kwiintwala kunye nokhwekhwe.”
“I-Cipher ithatha inyathelo elinesibindi neligxile kwizigulane ngokutyala imali kwimodeli yokhathalelo lwempilo yedijithali edibeneyo,” utshilo u-Areo Nazari, i-CEO yeCaryHealth. “Ngokudibanisa amayeza kagqirha, unxibelelwano noogqirha, kunye neenkonzo zekhemesti (kuquka ukuhanjiswa) kumava omnye, sinokunceda iintsapho zibuyele kwisiqhelo, ukususela kumzuzu abafuna unyango ukuya kumzuzu abalunyanga ngempumelelo.”
I-CaryHealth iphuhlise isisombululo esidibeneyo, esingenamthungo, nesibanzi sokhathalelo lwezigulane ngqo kwi-Natroba™ (echinococcin), iphucula amava okhathalelo ngokubanzi ngokunciphisa amaxesha okufikelela kunye nokususa imiqobo. Esi sisombululo sisusa iinkqubo zokhathalelo olubonakalayo ezingadibaniyo, ukungena okuninzi, kunye namanyathelo okuhlawula ahlukeneyo, sivumela izigulane ukuba zifumane amayeza afanelekileyo eklinikhi zikude, zonwabele ukuhanjiswa ngosuku olufanayo kwiikhemesti kuzwelonke kwicandelo lenkonzo yeCaryRx, kwaye zilandelele imeko yemithi ngexesha langempela nge-portal yeCaryConnect.
I-CaryHealth yinkampani yedijithali yamayeza kunye neteknoloji yezempilo esebenzisa ubukrelekrele bokwenziwa ukuguqula indlela abaguli abaqalisa kwaye banamathela ngayo kunyango. Iqonga lethu lidibanisa iinkonzo zekhemesti, ukuzenzekela okukrelekrele, kunye nokubandakanyeka okuqhutywa yidatha ukuphucula iinkqubo zezempilo, ukuphucula ukuqhubeka konyango, kunye nokuxhobisa abaguli kulo lonke ixesha lonyango. Ngokuvala umsantsa phakathi kwesayensi yobomi, ababoneleli bezempilo, kunye nezigulane, i-CaryHealth ikhuthaza ukufikelela ngokulinganayo kwizixhobo zezempilo kwaye inceda unyango olwahlukeneyo lufikelele kumandla alo apheleleyo.
I-Cipher Pharmaceuticals (TSX: CPH) (OTCQX: CPHRF) yinkampani ekhethekileyo yamayeza egxile kwi-dermatology enepotifoliyo etyebileyo neyahlukeneyo yeemveliso kunye neemveliso ezithengiswayo ekuqaleni nasekupheleni kophuhliso. I-Cipher topical Natroba™ kunye nenguqulelo yayo ye-generic enelayisenisi, i-spinosad, zezona mveliso zodwa ezifumene igama "elicacileyo" le-scabies kwi-US Food and Drug Administration (FDA). Ukongeza, i-Natroba™ (spinosad) yeyona kuphela unyango oluvunyiweyo yi-FDA lweentwala zentloko olubonakalise ukusebenza kakuhle kwezonyango xa kuthelekiswa ne-Nix® (1% permethrin) kwizilingo ezimbini zeklinikhi zeSigaba sesiThathu esithelekisayo. Akukho mfuneko yokukama amaqanda eentwala.
Ixesha leposi: Epreli-28-2026
